Connect with us

/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153

Cigna Collaboration Helps Santa Clara County IPA (SCCIPA) Improve Quality and Lower Costs

Published

on

Reading Time: 3 minutes

SANTA CLARA, Calif.–(BUSINESS WIRE)–The latest results from a collaboration between Cigna and Santa Clara
County IPA (SCCIPA) show that the program continues to drive better
health care quality for nearly 18,000 Silicon Valley residents while
achieving significantly better affordability.

SCCIPA enhances care by using patient-specific data from Cigna to help
identify individuals being discharged from the hospital who might be at
risk for readmission, as well as people who may be overdue for important
health screenings or who may have skipped a prescription refill. The
physician-led care team also helps patients get the follow-up care or
screenings they need, identifies potential complications related to
medications and helps prevent chronic conditions from worsening.

While SCCIPA already beats the market in affordability with total
medical costs that are 18 percent below market average, the medical
group’s cost trend was 2.6 percent lower than the market trend during
the period ending Sept. 30, 2018.

At the same time, the group’s quality score improved by double digits –
nearly 20 percentage points, led by better care of patients with cardiac
conditions, diabetes, depression and those requiring specific preventive
screenings.

Numerous factors contributed to SCCIPA’s strong performance results
compared to the market, including:

  • Hospital readmissions were 23 percent lower than market
  • Inpatient admissions among all services were 10 percent lower than
    market
  • Emergency room visits were 9 percent lower than market
  • Advanced imaging (CT scans and MRIs) were used 32 percent less than
    market
  • Inpatient total medical cost (per Cigna customer per month) was 20
    percent lower than market

“As a risk-bearing network of more than 800 physicians, we’re very
pleased with these positive results,” said John Kersten Kraft, M.D.,
president of SCCIPA. “SCCIPA is devoted to improving the measurable
quality of medical intervention received by our patients while
controlling the cost of their care. We value our strong and
exceptionally collaborative relationship with Cigna. Without this
relationship, these results could not be achieved. Together, we are
having a very positive impact on the health of our patients.”

“When health plans and health care providers work together toward a
common goal, the result is better health and affordability for the
people we jointly serve,” said Ken Phenow, M.D., M.P.H, market medical
executive for Cigna in Northern California. “We congratulate Santa Clara
County IPA for its laser focus on quality improvement that drove these
outstanding results.”

Since Cigna began collaborating with SCCIPA in 2014, the group has
demonstrated some of the most consistent performance, not only among
other medical groups in Northern California and Cigna’s Western Region,
but also among the more than 225 Collaborative Care arrangements Cigna
has with provider groups nationwide. In 2018, SCCIPA was the top
performing Cigna Collaborative Care group nationally.

In addition to its Collaborative Care arrangement with Cigna, SCCIPA is
also part of an alliance between Cigna and Good Samaritan Health System,
which includes Regional Medical Center of San Jose and Good Samaritan
Hospital. The alliance launched in January 2018 and offers a customized
network of primary care doctors, specialists and hospitals that provide
high value care.

About Santa Clara County IPA

Santa Clara County IPA (SCCIPA) has been providing exceptional
healthcare services for more than 30 years. More than 240 primary care
physicians and 600 specialists are focused on delivering the highest
quality of care, while driving lower cost of care for more than 90,000
members of major HMOs, PPOs, ACOs and Medicare Advantage programs.
SCCIPA’s mission is to connect patients to independent doctors who are
passionate about providing personalized care. The diverse network
includes access to 13 urgent care centers, 10 hospitals, radiology,
clinical labs, physical therapists, and case managers dedicated to
providing care with a purpose. SCCIPA offers a multitude of services for
members and is known for its Care Concierge program. The program is led
by a team of clinicians and is designed to engage patients and promote
healthy habits, behavioral change, improved health, and ultimately lower
cost of care by helping members be at their best. Visit www.sccipa.com.

About Cigna

Cigna Corporation (NYSE: CI) is a global health service company
dedicated to improving the health, well-being and peace of mind of those
we serve. Cigna delivers choice, predictability, affordability and
quality care through integrated capabilities and connected, personalized
solutions that advance whole person health. All products and services
are provided exclusively by or through operating subsidiaries of Cigna
Corporation, including Cigna Health and Life Insurance Company,
Connecticut General Life Insurance Company, Life Insurance Company of
North America, Cigna Life Insurance Company of New York, Express Scripts
companies or their affiliates. Such products and services include an
integrated suite of health services, such as medical, dental, behavioral
health, pharmacy, vision, supplemental benefits, and other related
products including group life, accident and disability insurance. Cigna
maintains sales capability in over 30 countries and jurisdictions, and
has more than 160 million customer relationships throughout the world.
To learn more about Cigna®, including links to follow us on
Facebook or Twitter, visit www.cigna.com.

Contacts

Mark Slitt
Cigna
860.226.2092
[email protected]

Janet Doherty Pulliam
Pacific Partners Management Services, Inc.
650.358.5715
[email protected]


Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493

Cannabis

Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III

Published

on

Continue Reading

Humboldt

Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace

Published

on

humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace

Apollo Green to distribute Humboldt Seed Company clonal cannabis genetics to Germany, Portugal and Australia

SAN FRANCISCO, April 30, 2024 /PRNewswire/ — Humboldt Seed Company (HSC), California’s leading cannabis seed producer, has announced a partnership with Canadian-based Apollo Green to make eight breeder cuts available to researchers, licensed commercial cultivators and home growers in legal markets worldwide. This first-to-market clonal genetics release is a significant milestone and will expand access to distinctive, high-quality cannabis genetics in both established and emerging global markets including Germany, Portugal and Australia.

The curated, breeder-verified selection includes pioneering triploid genetics, such as OG Triploid and Donutz Triploid alongside the legendary cult classic Blueberry Muffin. Also available are All Gas OG with a THC content of 21% and four high-THC strains in the 30-35% range: Golden Sands, Guzzlerz, Jelly Donutz and Orange Creampop. These selections represent the top .01% from HSC’s extensive California pheno-hunting program.

Exports will begin in May under Apollo Green’s Canadian federal cannabis license. All shipments have Canadian phytosanitary certification, ensuring plants have been inspected, and are clean and free of pests.

“Access for all to quality genetics has been our core focus since the beginning,” said HSC Co-founder and Chief Science Officer, Benjamin Lind. “Our science-based approach to breeding aligns perfectly with Apollo Green’s high standards and we are excited to be able to extend these hand-selected cuts to a wider audience, especially at this pivotal time where we’re seeing positive regulatory changes globally.”

Oisin Tierney, Apollo Green Director of Business Development, said, “California has long been recognized for setting industry standards, and we are proud to play a role in bringing these esteemed genetics to cultivators worldwide. The triploids are especially noteworthy in terms of the unprecedented potential for enhanced plant vigor, higher yields, shorter flowering times and superior returns for solventless extraction.”

About Humboldt Seed Company

Established in 2001, Humboldt Seed Company is a Northern California heritage brand providing quality cannabis genetics to commercial cultivators and home growers in legalized states across the U.S. and international markets including Spain, Canada, Jamaica, South Africa, Colombia, France, Portugal, Greece, the UK, Malta and Thailand. With a focus on environmental and social justice, they combine traditional breeding and modern scientific practices in their strain development program. They have served the cannabis community for over two decades.

For more information visit https://humboldtseedcompany.com/.

About Apollo Green

Licensed since 2019, Apollo Green is Canada’s leader in cannabis genetics. The company’s mission is to provide an ever-growing bank of seeds and clones to medical patients and recreational consumers. Apollo Green provides clean, trusted cannabis seeds and clones, which are backed by the foremost tissue culture technology to reduce risks, costs and time-to-market for licensed producers around the world. Apollo Green is passionate about cannabis genetics. 

For more information visit https://apollogreen.com/.

Media contact
Jaana Prall
[email protected] 

Logo – https://mma.prnewswire.com/media/2328955/Humboldt_Seed_Company_Logo.jpg 

Cision View original content:https://www.prnewswire.co.uk/news-releases/humboldt-seed-company-partners-with-apollo-green-to-bring-california-cannabis-genetics-to-the-global-marketplace-302131618.html

Continue Reading

Cannabis

Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety

Published

on

Continue Reading
Advertisement

Latest news

Trending on Grassnews

GrassNews.net: Your premier portal for the latest developments in the cannabis industry. We provide timely news, insightful analysis, and in-depth features on everything from legislation changes and business trends, to scientific research and lifestyle topics. Stay informed and navigate the rapidly evolving cannabis landscape with GrassNews.net..

Contact us: [email protected]

Editorial / PR Submissions

Copyright © 2007 - 2024 Hipther Agency. Registered in Romania under Proshirt SRL, Company number: 2134306, EU VAT ID: RO21343605. Office address: Blvd. 1 Decembrie 1918 nr.5, Targu Mures, Romania